Detalles de la búsqueda
1.
High-value breast cancer care within resource limitations.
Oncologist
; 2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38780115
2.
Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium.
Breast Cancer Res Treat
; 203(2): 351-363, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37878152
3.
Implementing and monitoring the right to health in breast cancer: selection of indicators using a Delphi process.
Int J Equity Health
; 22(1): 142, 2023 07 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37507731
4.
Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the Belgian and Luxembourg Gynaecological Oncology Group.
Int J Gynecol Cancer
; 32(6): 753-760, 2022 06 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35063943
5.
Correction: Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium.
Breast Cancer Res Treat
; 206(1): 207, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38592543
6.
Phase II study of weekly paclitaxel/carboplatin in combination with prophylactic G-CSF in the treatment of gynecologic cancers: A study in 108 patients by the Belgian Gynaecological Oncology Group.
Gynecol Oncol
; 138(2): 278-84, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26049123
7.
Comparing duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial: application of new methodology.
Breast Cancer Res Treat
; 138(1): 149-55, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23378064
8.
Trends and variation in treatment of early breast cancer in European certified breast centres: an EUSOMA-based analysis.
Eur J Cancer
; 192: 113244, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37633095
9.
High-grade serous cancer of undetermined primary origin presenting as solitary inguinal lymph node enlargement.
BMJ Case Rep
; 14(4)2021 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33910789
10.
New Frontiers for Fairer Breast Cancer Care in a Globalized World.
Eur J Breast Health
; 17(2): 86-94, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33870106
11.
Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study.
Adv Ther
; 38(1): 350-365, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33123968
12.
The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer and non-Hodgkin's lymphoma.
BMC Cancer
; 10: 642, 2010 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-21092320
13.
Breast Cancer: global quality care optimizing care delivery with existing financial and personnel resources.
ESMO Open
; 4(Suppl 2): e000861, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32895233
14.
Neutropenia management in patients receiving myelosuppressive polychemotherapy for early breast cancer in Belgium: BRONS study results.
Acta Clin Belg
; 75(2): 128-135, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30609907
15.
First-line vs second-line fulvestrant for hormone receptor-positive advanced breast cancer: A post-hoc analysis of the CONFIRM study.
Breast
; 38: 144-149, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29324303
16.
Managing cancer care through service delivery networks: The role of professional collaboration in two European cancer networks.
Health Serv Manage Res
; 31(3): 120-129, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29239683
17.
UCBG 2-08: 5-year efficacy results from the UNICANCER-PACS08 randomised phase III trial of adjuvant treatment with FEC100 and then either docetaxel or ixabepilone in patients with early-stage, poor prognosis breast cancer.
Eur J Cancer
; 103: 184-194, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30267987
18.
Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter Trial.
Clin Cancer Res
; 24(10): 2312-2318, 2018 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29459457
19.
Neoadjuvant dual anti-HER2 therapy for early breast cancer: where do we stand?
Gland Surg
; 9(5): 1167-1169, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33224790
20.
Final overall survival: fulvestrant 500 mg vs 250 mg in the randomized CONFIRM trial.
J Natl Cancer Inst
; 106(1): djt337, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24317176